Concepedia

Publication | Open Access

Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma

DOIFull Paper Access

31

Citations

42

References

2021

Year

Carmen Álvarez‐Fernández, Laura Escribà-García, AC Caballero, Eva Escudero‐López, Cristina Ujaldón‐Miró, Rosanna Montserrat‐Torres, Paula Pujol‐Fernández, Jorge Sierra, Javier Briones
Clinical & Translational Immunology

Abstract

This study supports the use of a refined CD30-CAR T cells with highly enriched T<sub>SCM-like</sub> products to improve clinical efficacy of CAR T for Hodgkin lymphoma.

References

YearCitations

Page 1